Cargando…
Willingness to pay for medications among patients with Rome IV Irritable Bowel Syndrome
BACKGROUND: Little is known about willingness to pay for medications among individuals with irritable bowel syndrome (IBS). METHODS: We collected demographic, gastrointestinal symptom, psychological health, quality of life, and healthcare usage data from 752 adults with Rome IV‐defined IBS. We exami...
Autores principales: | Goodoory, Vivek C., Ng, Cho Ee, Black, Christopher J., Ford, Alexander C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078431/ https://www.ncbi.nlm.nih.gov/pubmed/36178331 http://dx.doi.org/10.1111/nmo.14483 |
Ejemplares similares
-
Willingness to accept risk with medication in return for cure of symptoms among patients with Rome IV irritable bowel syndrome
por: Goodoory, Vivek C., et al.
Publicado: (2022) -
Direct healthcare costs of Rome IV or Rome III‐defined irritable bowel syndrome in the United Kingdom
por: Goodoory, Vivek C., et al.
Publicado: (2022) -
Impact of Rome IV irritable bowel syndrome on work and activities of daily living
por: Goodoory, Vivek C., et al.
Publicado: (2022) -
Latent class analysis does not support the existence of Rome IV functional bowel disorders as discrete entities
por: Black, Christopher J., et al.
Publicado: (2022) -
Health care utilization of individuals with Rome IV irritable bowel syndrome in the general population
por: Tornkvist, Navkiran T., et al.
Publicado: (2021)